6 TECH OUTLOOKDecember - 2019EditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe pharma industry is going through a rapid transformation driven by the latest technologies, rise in R&D, government funding and growth in clinical trials. Traditionally, data collected from clinical trials were handled using in-house programs as the number of patients and tests were small. However, in the current scenario--the surge in clinical trials around the globe resulted in the overflow of data, owing to drug-discoveries, new ailments and their outcomes being recorded. This requires collecting massive amounts of patient data as well as ensuring its security and qualitative parameters. That being said, Clinical trials require heavy supervision for successful assessment and adoption of the latest technologies, and application software can vastly improve efficiency. In addition, regulations such as HIPPA and GDPR have made it necessary for researches to employ and manage patient data with utmost caution. One of the latest trends, the industry is witnessing is the integration of Clinical Trial Management Systems (CTMS) with AI and machine learning to support multiple studies together in real-time.The global Clinical solutions market is expected to experience a 12 percent CAGR growth and surpass 11 billion Euros by 2024. Thus, Competition among CTMS providers will be set to increase, and players must seek to stay ahead or keep-pace with the changes to thwart the market. To make this task easier and empower businesses to remain competitive and innovative, the editorial board of Pharma Tech Outlook presents to you a special edition of Clinical Trial Management Europe 2019. This magazine features insights from industry leaders such as Trilogy Writing & Consulting, offering an in-depth view of technologies that are stirring a revolution in this space. The list consists of Clinical Trial Management solution providers that have developed innovative solutions to address the dynamic challenges of the sector. We hope this special edition will assist you in revamping your enterprise's Trial Management strategy. Let us know your thoughts.Renaissance in Clinical Trial ManagementCopyright © 2019 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.DECEMBER - 19 - 2019, Vol 05 - Issue 20 (ISSN 2644-2787) Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405Albert RozarioTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >